l.solberg

TL2 · Medellín

Contributes reviews on supplier material. Based in Medellín.

Joined 6 April 2025 · last posted 4d

80Posts here

4Topics

1Solutions

904Likes received

716Likes given

21Badges

193Days visited

3.5kPosts read

Recent activity

Full stream

Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #93 · Practice › Dosing & titration · 24 Jul 2026 · 26 likes Answering the question post #89 raises rather than the one it answers. Research-use-only material is not a licensed product and no labelling covers it. Everything in…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #34 · Access › Insurance & coverage · 16 Jul 2026 · 22 likes Offering a way to settle Prior authorisation rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
Common supplements people ask about, assessed one at a time Replied, post #54 · Practice › Interactions · 16 Jul 2026 · 4 likes Noted, and thank you for writing it out rather than summarising it.
What I would want from a home test that does not exist yet Replied, post #37 · Analytics › Home & field testing · 14 Jul 2026 · 0 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it.
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #36 · Evidence › Journal club · 8 Jul 2026 · 0 likes SUSTAIN 6 has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Journal club: what we got wrong in an earlier session Replied, post #61 · Evidence › Journal club · 7 Jul 2026 · 11 likes Reading a preprint in a session is fine provided the status is stated in the first minute and stays in the summary.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #93 · Safety › Contraindications · 30 Jun 2026 · 25 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #67 · Compounds › Semaglutide · 17 Jun 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #35 · Analytics › Home & field testing · 15 Jun 2026 · 10 likes Adding what did not work for me on home kit substitute, since the failures never get written up and they are half the useful information.
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #111 · Practice › Storage & stability · 9 Jun 2026 · 24 likes Taking post #108 at face value and following it one step further. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
Pooling trials with different estimands Replied, post #9 · Evidence › Meta-analyses · 6 Jun 2026 · 8 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. Someone should write…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #114 · Compounds › Tirzepatide · 1 Jun 2026 · 13 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…